Ozempic (Semaglutide) Price by US State (2026 Analysis)
Estimated Ozempic (Semaglutide) retail and out-of-pocket cost (per month supply) across all 50 US states, compared with international pharmaceutical benchmarks in India (approx. $80). US state figures represent modeled healthcare-cost adjustments from the national baseline ($950).
State Price Variations for Ozempic (Semaglutide)
51 States & TerritoriesComplete State Cost Table
| State | US Price (Est.) | India Price | You Save |
|---|---|---|---|
| Alabama | $855 | $80 | $775 |
| Alaska | $1,216 | $80 | $1,136 |
| Arizona | $950 | $80 | $870 |
| Arkansas | $836 | $80 | $756 |
| California | $1,235 | $80 | $1,155 |
| Colorado | $1,026 | $80 | $946 |
| Connecticut | $1,159 | $80 | $1,079 |
| Delaware | $998 | $80 | $918 |
| Florida | $969 | $80 | $889 |
| Georgia | $912 | $80 | $832 |
| Hawaii | $1,254 | $80 | $1,174 |
| Idaho | $903 | $80 | $823 |
| Illinois | $1,007 | $80 | $927 |
| Indiana | $903 | $80 | $823 |
| Iowa | $884 | $80 | $804 |
| Kansas | $874 | $80 | $794 |
| Kentucky | $855 | $80 | $775 |
| Louisiana | $884 | $80 | $804 |
| Maine | $1,007 | $80 | $927 |
| Maryland | $1,121 | $80 | $1,041 |
| Massachusetts | $1,216 | $80 | $1,136 |
| Michigan | $931 | $80 | $851 |
| Minnesota | $1,007 | $80 | $927 |
| Mississippi | $817 | $80 | $737 |
| Missouri | $874 | $80 | $794 |
| Montana | $931 | $80 | $851 |
| Nebraska | $893 | $80 | $813 |
| Nevada | $969 | $80 | $889 |
| New Hampshire | $1,064 | $80 | $984 |
| New Jersey | $1,159 | $80 | $1,079 |
| New Mexico | $893 | $80 | $813 |
| New York | $1,235 | $80 | $1,155 |
| North Carolina | $912 | $80 | $832 |
| North Dakota | $922 | $80 | $842 |
| Ohio | $912 | $80 | $832 |
| Oklahoma | $846 | $80 | $766 |
| Oregon | $1,045 | $80 | $965 |
| Pennsylvania | $988 | $80 | $908 |
| Rhode Island | $1,083 | $80 | $1,003 |
| South Carolina | $903 | $80 | $823 |
| South Dakota | $903 | $80 | $823 |
| Tennessee | $874 | $80 | $794 |
| Texas | $950 | $80 | $870 |
| Utah | $950 | $80 | $870 |
| Vermont | $1,064 | $80 | $984 |
| Virginia | $1,007 | $80 | $927 |
| Washington | $1,121 | $80 | $1,041 |
| Washington, D.C. | $1,273 | $80 | $1,193 |
| West Virginia | $855 | $80 | $775 |
| Wisconsin | $950 | $80 | $870 |
| Wyoming | $931 | $80 | $851 |
Frequently Asked Questions: Ozempic (Semaglutide) Pricing
Why do Ozempic (Semaglutide) prices differ across US states?+
Prescription drug prices in the US vary by state due to differing pharmacy dispensing fee regulations, state tax laws, regional wholesale distribution costs, and varying health insurance plan coverage formularies. Out-of-pocket prices can differ by hundreds of dollars even between neighboring states.
How does the US price of Ozempic (Semaglutide) compare to international prices?+
In the United States, Ozempic (Semaglutide) averages approximately $950 per month supply. In India, certified manufacturers produce equivalent formulations and authorized generics for about $80 per month supply — saving patients up to 90%+ without compromising therapeutic equivalence.
Are generic or biosimilar versions of Ozempic (Semaglutide) available?+
Depending on patent expiry schedules, authorized generic alternatives and international equivalents may be accessible through licensed personal importation channels.
Other Diabetes Medications
Farxiga (Dapagliflozin)
Farxiga (dapagliflozin) is a once-daily SGLT2 inhibitor used for type 2 diabetes, heart failure, and chronic kidney disease. Indian generics of dapagliflozin make the monthly cost dramatically lower than in the USA.
Glipizide
Glipizide is an oral sulfonylurea that stimulates insulin release to lower blood sugar in type 2 diabetes. Generic glipizide is very inexpensive in India.
Insulin (Lantus/Humalog)
Insulin is an injectable hormone therapy used by people with type 1 and type 2 diabetes to control blood sugar levels. Long-acting versions like Lantus (glargine) provide steady background coverage, while rapid-acting Humalog (lispro) is taken around meals. In the USA a month's supply often runs into the hundreds of dollars even with insurance, whereas Indian pharmacies stock the same molecules — including biosimilar insulins from local manufacturers — at a small fraction of the price.